ETC BioMedical Systems
News Release

Click CTRL + p to print.

ETC Announces Monoplace Hyperbaric Chamber Sale

Southampton, PA: February 21, 2008 - Environmental Tectonics Corporation's (Amex: ETC | news | PowerRating | PR Charts ) ("ETC" or the "Company") BioMedical Division announced today it has been awarded a contract for a BARA-MED monoplace hyperbaric chamber to be sold through ETC's Polish subsidiary, ETC- PZL Aerospace Industries. In obtaining this contract, ETC worked closely with ETC-PZL to help ensure that the hyperbaric chamber installation met requirements for operational efficiency, patient comfort, and the latest safety standards for healthcare facilities.

ETC is the manufacturer of the BARA-MED® and BARA-MED® XD, the industry's most technically advanced hyperbaric chambers. These chambers include a 4th generation Windows® based operating systems which controls and records chamber activity. ETC hyperbaric chambers remain the leader in providing a patient friendly pressurization alternative (Smooth Ride™) that minimizes complications due to middle ear and sinus barotraumas without increasing compression time. In addition to their regular use in clinical treatments at medical facilities around the world, ETC hyperbaric chambers are routinely involved in research on new indications for which hyperbaric oxygen therapy (HBO) holds promise.

Gene Davis, President of ETC's BioMedical Division, commented, "We are pleased to see ourselves leaving a larger footprint on the international market"


FOR MORE INFORMATION ON ETC CONTACT:
Duane D. Deaner, CFO of Environmental Tectonics
Tel: 215-355-9100, ext.1203
Fax: 215-357-4000.

Visit www.etchyperbaricchambers.com to learn more.
 

ETC designs, develops, installs and maintains aircrew training systems, public entertainment systems, process simulation systems (sterilization and environmental), clinical hyperbaric systems, environmental testing and simulation systems, and related products for domestic and international customers.

This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934. We have based these forward- looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about the Company that may cause our actual results, levels of activity, performance or achievements to be materially different from any other future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements include statements with respect to ETC's vision, mission, strategies, goals, beliefs, plans, objectives, expectations, anticipations, estimates, intentions, financial condition, results of operations, future performance and business of ETC, including but not limited to, (i) projections of revenue, costs of raw materials, income or loss, earnings or loss per share, capital expenditures, growth prospects, dividends, capital structure, other financial items and the effects of currency fluctuations, (ii) statements of plans and objectives of ETC or its management or Board of Directors, including the introduction of new products, or estimates or predictions of actions of customers, suppliers, competitors or regulatory authorities, (iii) statements of future economic performance, (iv) statements of assumptions and other statements about ETC or its business, (v) statements made about the possible outcomes of litigation involving ETC, and (vi) statements preceded by, followed by or that include the words "may", "could", "should", "looking forward", "would", "believe", "expect", "anticipate", "estimate", "intend", "plan", or the negative of such terms or similar expressions. These forward-looking statements involve risks and uncertainties which are subject to change based on various important factors. Some of these risks and uncertainties, in whole or in part, are beyond ETC's control. Factors that might cause or contribute to such a material difference include, but are not limited to, those discussed in our Securities and Exchange Commission filings and other public documents, including, without limitation, our Annual Report on Form 10-K for the fiscal year ended February 23, 2007. Shareholders are urged to review these risks carefully prior to making an investment in the ETC's common stock.

The Company cautions that the foregoing list of important factors is not exclusive. ETC does not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by or on behalf of ETC.